Bluesphere Bio, Inc
Clinical trials sponsored by Bluesphere Bio, Inc, explained in plain language.
-
New cell therapy targets tough blood cancer in early trial
Disease control Recruiting nowThis early-phase study tests a new cell therapy called BSB-2002 in adults with a specific type of acute myeloid leukemia (AML) that has returned or not responded to at least two prior treatments. The main goal is to check the safety of BSB-2002 and see if it can help prevent the …
Phase: PHASE1 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New cell therapy aims to stop blood cancers from coming back
Disease control Recruiting nowThis study tests a new treatment called BSB-1001 for people with certain blood cancers (AML, ALL, or MDS) who have had a stem cell transplant. The therapy uses specially modified immune cells to target and kill cancer cells while trying to avoid harming healthy tissue. The main g…
Phase: PHASE1, PHASE2 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated May 13, 2026 15:59 UTC